{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,20]],"date-time":"2026-10-20T16:43:25Z","timestamp":1792514605332,"version":"4.5.0"},"reference-count":32,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2020,8,31]],"date-time":"2020-08-31T00:00:00Z","timestamp":1598832000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Med."],"DOI":"10.3389\/fmed.2020.00511","type":"journal-article","created":{"date-parts":[[2020,8,31]],"date-time":"2020-08-31T15:06:13Z","timestamp":1598886373000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":35,"title":["The Bidirectional Association Between Bullous Pemphigoid and Psoriasis: A Population-Based Cohort Study"],"prefix":"10.3389","volume":"7","author":[{"given":"Khalaf","family":"Kridin","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ralf J.","family":"Ludwig","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yochai","family":"Schonmann","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giovanni","family":"Damiani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Arnon D.","family":"Cohen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2020,8,31]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"6","DOI":"10.1007\/s12026-017-8975-2","article-title":"Subepidermal autoimmune bullous diseases: overview, epidemiology, and associations","volume":"66","author":"Kridin","year":"2018","journal-title":"Immunol Res."},{"key":"B2","doi-asserted-by":"publisher","first-page":"87","DOI":"10.1111\/bjd.14821","article-title":"Hospitalization, inpatient burden and comorbidities associated with bullous pemphigoid in the U.S.A","volume":"176","author":"Ren","year":"2017","journal-title":"Br J Dermatol."},{"key":"B3","doi-asserted-by":"publisher","first-page":"220","DOI":"10.3389\/fmed.2018.00220","article-title":"The growing incidence of bullous pemphigoid: overview and potential explanations","volume":"5","author":"Kridin","year":"2018","journal-title":"Front Med"},{"key":"B4","doi-asserted-by":"publisher","first-page":"1094","DOI":"10.1111\/1346-8138.14503","article-title":"Mortality in bullous pemphigoid: a systematic review and meta-analysis of standardized mortality ratios","volume":"45","author":"Kridin","year":"2018","journal-title":"J Dermatol."},{"key":"B5","doi-asserted-by":"publisher","first-page":"72","DOI":"10.2340\/00015555-2930","article-title":"Mortality in patients with bullous pemphigoid: a retrospective cohort study, systematic review and meta-analysis","volume":"99","author":"Kridin","year":"2018","journal-title":"Acta Derm Venereol."},{"key":"B6","doi-asserted-by":"publisher","first-page":"1296","DOI":"10.1111\/bjd.18731","article-title":"Assessment of healthcare costs for patients with pemphigus and bullous pemphigoid in an academic centre in Germany","volume":"182","author":"St\u00e4nder","year":"2019","journal-title":"Br J Dermatol"},{"key":"B7","doi-asserted-by":"publisher","first-page":"320","DOI":"10.1016\/S0140-6736(12)61140-4","article-title":"Pemphigoid diseases","volume":"381","author":"Schmidt","year":"2013","journal-title":"Lancet."},{"key":"B8","doi-asserted-by":"publisher","first-page":"377","DOI":"10.1038\/jid.2012.339","article-title":"Global epidemiology of psoriasis: a systematic review of incidence and prevalence","volume":"133","author":"Parisi","year":"2012","journal-title":"J Invest Dermatol."},{"key":"B9","doi-asserted-by":"publisher","first-page":"983","DOI":"10.1016\/S0140-6736(14)61909-7","article-title":"Psoriasis","volume":"386","author":"Boehncke","year":"2015","journal-title":"Lancet."},{"key":"B10","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1111\/imm.12891","article-title":"Autoimmunity and autoimmune co-morbidities in psoriasis","volume":"154","author":"Furue","year":"2018","journal-title":"Immunology"},{"key":"B11","doi-asserted-by":"publisher","first-page":"1764","DOI":"10.3389\/fimmu.2019.01764","article-title":"Adaptive and innate immunity in psoriasis and other inflammatory disorders","volume":"10","author":"Sch\u00f6n","year":"2019","journal-title":"Front Immunol"},{"key":"B12","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1111\/ajd.12899","article-title":"Association between bullous pemphigoid and psoriasis: Systematic review and meta-analysis of case-control studies","volume":"60","author":"Phan","year":"2019","journal-title":"Australas J Dermatol"},{"key":"B13","doi-asserted-by":"publisher","first-page":"547","DOI":"10.1093\/oxfordjournals.aje.a113439","article-title":"On the need for the rare disease assumption in case-control studies","volume":"116","author":"Greenland","year":"1982","journal-title":"Am J Epidemiol"},{"key":"B14","first-page":"204","article-title":"The quality indigators program in Clalit Health services: the first decade","volume":"149","author":"Cohen","year":"2010","journal-title":"Harefuah"},{"key":"B15","doi-asserted-by":"publisher","first-page":"373","DOI":"10.1016\/0021-9681(87)90171-8","article-title":"A new method of classifying prognostic comorbidity in longitudinal studies: development and validation","volume":"40","author":"Charlson","year":"1987","journal-title":"J Chronic Dis."},{"key":"B16","doi-asserted-by":"publisher","first-page":"e0181039","DOI":"10.1371\/journal.pone.0181039","article-title":"An update on psoriasis and metabolic syndrome: a meta-analysis of observational studies","volume":"12","author":"Singh","year":"2017","journal-title":"PLoS ONE"},{"key":"B17","doi-asserted-by":"publisher","first-page":"157","DOI":"10.1684\/ejd.2018.3243","article-title":"Comorbidities of bullous pemphigoid in a Finnish cohort","volume":"28","author":"Pankakoski","year":"2018","journal-title":"Eur J Dermatol."},{"key":"B18","first-page":"254","article-title":"Psoriasis with superimposed bullous eruption","volume":"20","author":"Bloom","year":"1929","journal-title":"Arch Dermatol."},{"key":"B19","doi-asserted-by":"publisher","first-page":"50","DOI":"10.1016\/j.jaad.2015.03.016","article-title":"Coexistence of autoimmune bullous diseases (AIBDs) and psoriasis: A series of 145 cases","volume":"73","author":"Ohata","year":"2015","journal-title":"J Am Acad Dermatol."},{"key":"B20","doi-asserted-by":"publisher","first-page":"1353","DOI":"10.1111\/j.1365-4632.2006.02861.x","article-title":"Concomitant psoriasis and bullous pemphigoid: coincidence or pathogenic relationship?","volume":"45","author":"Wilczek","year":"2006","journal-title":"Int J Dermatol."},{"key":"B21","doi-asserted-by":"publisher","first-page":"392","DOI":"10.1046\/j.1365-2133.2002.04637.x","article-title":"Changes in the distribution of laminin alpha1 chain in psoriatic skin: immunohistochemical study using confocal laser scanning microscopy","volume":"146","author":"Vaccaro","year":"2002","journal-title":"Br J Dermatol."},{"key":"B22","doi-asserted-by":"publisher","first-page":"527","DOI":"10.1007\/BF02505249","article-title":"Behaviour of laminin 1 and type IV collagen in uninvolved psoriatic skin. immunohistochemical study using confocal laser scanning microscopy","volume":"288","author":"Mondello","year":"1996","journal-title":"Arch Dermatol Res."},{"key":"B23","doi-asserted-by":"publisher","first-page":"718","DOI":"10.1111\/bjd.12400","article-title":"Psoriasis and basement-membrane laminin","volume":"169","author":"McFadden","year":"2013","journal-title":"Br J Dermatol"},{"key":"B24","doi-asserted-by":"publisher","first-page":"175","DOI":"10.1146\/annurev-pathol-012615-044313","article-title":"Mechanisms of disease: pemphigus and bullous pemphigoid","volume":"11","author":"Hammers","year":"2016","journal-title":"Annu Rev Pathol Mech Dis."},{"key":"B25","doi-asserted-by":"publisher","first-page":"222","DOI":"10.3389\/fmed.2018.00222","article-title":"Interaction of psoriasis and bullous diseases","volume":"5","author":"Dainichi","year":"2018","journal-title":"Front Med"},{"key":"B26","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1002\/jcp.21300","article-title":"Transcriptional responses of human epidermal keratinocytes to cytokine interleukin-1","volume":"214","author":"Yano","year":"2008","journal-title":"J Cell Physiol."},{"key":"B27","doi-asserted-by":"publisher","first-page":"142","DOI":"10.1016\/0923-1811(95)00435-1","article-title":"Detection of IL-1\u03b1, IL-1\u03b2 and IL-1 receptor antagonist in blister fluid of bullous pemphigoid","volume":"11","author":"Schmidt","year":"1996","journal-title":"J Dermatol Sci."},{"key":"B28","doi-asserted-by":"publisher","first-page":"611","DOI":"10.1046\/j.1365-2133.1998.02169.x","article-title":"Cytokine pattern in blister fluid and serum of patients with bullous pemphigoid: relationships with disease intensity","volume":"138","author":"Ameglio","year":"1998","journal-title":"Br J Dermatol."},{"key":"B29","doi-asserted-by":"publisher","first-page":"3656","DOI":"10.4049\/jimmunol.1402688","article-title":"Caspase-1\u2013independent IL-1 release mediates blister formation in autoantibody-induced tissue injury through modulation of endothelial adhesion molecules","volume":"194","author":"Sadeghi","year":"2015","journal-title":"J Immunol"},{"key":"B30","doi-asserted-by":"publisher","first-page":"1022","DOI":"10.1111\/j.1600-0625.2011.01378.x","article-title":"Lesional Th17 cells and regulatory T cells in bullous pemphigoid","volume":"20","author":"Arakawa","year":"2011","journal-title":"Exp Dermatol"},{"key":"B31","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1016\/j.jaad.2018.06.056","article-title":"Psoriasis: which therapy for which patient: psoriasis comorbidities and preferred systemic agents","volume":"80","author":"Kaushik","year":"2019","journal-title":"J Am Acad Dermatol"},{"key":"B32","doi-asserted-by":"publisher","first-page":"43","DOI":"10.1016\/j.jaad.2018.06.056","article-title":"Psoriasis: which therapy for which patient: focus on special populations and chronic infections","volume":"80","author":"Kaushik","year":"2019","journal-title":"J Am Acad Dermatol"}],"container-title":["Frontiers in Medicine"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/article\/10.3389\/fmed.2020.00511\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,8,31]],"date-time":"2020-08-31T15:06:14Z","timestamp":1598886374000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/article\/10.3389\/fmed.2020.00511\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,8,31]]},"references-count":32,"alternative-id":["10.3389\/fmed.2020.00511"],"URL":"https:\/\/doi.org\/10.3389\/fmed.2020.00511","relation":{},"ISSN":["2296-858X"],"issn-type":[{"value":"2296-858X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,8,31]]},"article-number":"511"}}